Tenax Therapeutics Inc news

   Watch this stock
Showing stories 1 - 10 of about 17   

Articles published

TENX 3.95 +0.01 (0.38%)
price chart
Tenax Therapeutics Analyst Brief: Emerging Biopharmaceutical Player Back In ...
NEW YORK, Oct. 31, 2014 /PRNewswire/ -- Analyst Brief by Small Cap Traders. Tenax Therapeutics, Inc. TENX, +2.87% an emerging competitor, is engaged in the business of developing biotechnology products in the nature of blood substitutes with a focus ...
Tenax Therapeutics (TENX) Jumps: Stock Moves Up 7.8%
Tenax Therapeutics, Inc. (TENX) was a big mover last session, as its shares rose nearly 8% on the day. The move came on solid volume too with far more shares changing hands than in a normal session.
Related articles »  
Achillion Pharmaceuticals Inc (ACHN), Tenax Therapeutics Inc (TENX): Peter ...
As a result, RA Capital Management is left holding 8.03 million shares of Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN). In another move, the fund's manager, Peter Kolchinsky, has initiated a position in Tenax Therapeutics Inc (NASDAQ:TENX). According ...
Related articles »  
Tenax Therapeutics Announces First Quarter Fiscal Year 2015 Financial Results
MORRISVILLE, N.C.--(Business Wire)--Tenax Therapeutics, Inc. (NASDAQ: TENX), formerly Oxygen Biotherapeutics, Inc., a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care market, ...
Related articles »